Evidence map›Paper›PMID 37328486›Full record

ArticleScientific reports2023

The overexpression and clinical significance of TBX15 in human gliomas.

Dongming Yan, Yaping Yu, Qiongwei Ni, Qingwen Meng, Haolin Wu, Shun Ding, Xiaoqian Liu, Caiying Tang, Qibing Liu, Kun Yang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dongming Yan *Department of Neurosurgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, China.
Yaping Yu *Tumor Institute and Medical Research Central of The First Affiliated Hospital, Haikou, 570102, China.
Qiongwei Ni *Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, 570208, China.
Qingwen MengDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, China.
Haolin WuDepartment of Pharmacology, Hainan Medical University, Haikou, 571199, China.
Shun DingDepartment of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, China.
Xiaoqian LiuThe First Affiliated Hospital Trauma Center, Hainan Medical University, Haikou, 570100, China.
Caiying TangDepartment of Neurosurgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, China.
Qibing LiuDepartment of Pharmacology, Hainan Medical University, Haikou, 571199, China. qibing.liu@hainmc.edu.cn.
Kun YangDepartment of Neurosurgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, China. chbyk1379@163.com.
Hainan Medical University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-box transcription factor 15 (TBX15) is upregulated in a variety of tumors and has been reported to promote uncontrolled proliferation of tumor cells and induce tumor cells to avoid apoptosis, thus accelerating the malignant transformation of malignant tumors. However, the prognostic value of TBX15 in glioma and its relationship with immune infiltration remain unknown. In this study, we intended to explore the prognostic value of TBX15 and its link to glioma immune infiltration and examine TBX15 expression in pan-cancer using RNAseq data in TPM format from TCGA and GTEx. TBX15 mRNA and protein expressions in glioma cells and adjacent normal tissue were detected and compared by RT-qPCR and Western blot. The effect of TBX15 on survival was assessed by Kaplan-Meier Method. The correlation between TBX15 upregulation and the clinicopathological characteristics of glioma patients was assessed by using TCGA databases, and the relationship between TBX15 and other genes in glioma was evaluated by using TCGA data. The top 300 genes most significantly associated with TBX15 were selected to establish a PPI network through the STRING database. The relationship between TBX15 mRNA expression and immune cell infiltration was explored by using ssGSEA and the TIMER Database. It was found that TBX15 mRNA expression in glioma tissues was significantly higher than that in the adjacent normal tissues, and this difference was most obvious in high-grade gliomas. TBX15 expression was increased in human gliomas and associated with worse clinicopathological characteristics and poorer survival prognosis in glioma patients. In addition, elevated TBX15 expression was linked to a collection of genes involved in immunosuppression. In conclusion, TBX15 played an important role in immune cell infiltration in glioma and may prove to be a predictor of the prognosis in glioma patients.

Indexed as

Brain NeoplasmsGliomaClinical RelevanceHumansPrognosisRNA, MessengerT-Box Domain ProteinsRNA, MessengerT-Box Domain ProteinsTBX15 protein, human

Identifiers

PMID37328486
PMCPMC10276039
OpenAlexW4380992572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.